Clinical Trials Browser

Phase 2 × Colorectal Cancer Metastatic × durvalumab × Clear all

NCT03007407 2022-12-05

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

Phase 2 Completed

33 enrolled 8 charts

Gastrointestinal

Colorectal Cancer Metastatic